BNL Sciences Limited, headquartered in Ireland (IE), is a prominent player in the biotechnology and life sciences industry. Founded in [year], the company has established itself as a leader in innovative solutions, focusing on research and development, diagnostics, and therapeutic products. With a strong operational presence across Europe and beyond, BNL Sciences is dedicated to advancing healthcare through cutting-edge technology. The company’s core offerings include [specific products/services], which are distinguished by their unique approach to [specific features or benefits]. BNL Sciences has achieved significant milestones, including [notable achievements], solidifying its market position as a trusted provider in the life sciences sector. With a commitment to quality and innovation, BNL Sciences Limited continues to drive progress in the industry, making a meaningful impact on global health.
How does BNL Sciences Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
BNL Sciences Limited's score of 30 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, BNL Sciences Limited reported total carbon emissions of approximately 4,183,880 kg CO2e. This figure includes 342,450 kg CO2e from Scope 1 emissions, 40,430 kg CO2e from Scope 2 emissions, and a significant 2,801,000 kg CO2e from Scope 3 emissions. The combined Scope 1 and 2 emissions totalled about 382,880 kg CO2e. Despite the substantial emissions, BNL Sciences Limited has not set specific reduction targets or initiatives as part of their climate commitments. There are no documented SBTi (Science Based Targets initiative) reduction targets or other formal climate pledges. The company’s emissions data is not cascaded from a parent organization, indicating that it operates independently in its reporting. The company has disclosed emissions data for multiple years, with a notable focus on Scope 3 emissions, which account for the majority of their carbon footprint. This highlights the importance of addressing indirect emissions in their overall climate strategy.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | 342,450 |
| Scope 2 | 40,430 |
| Scope 3 | 2,801,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
BNL Sciences Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

